Speakers

Expand/Collapse

William Elmquist
Distinguished Professor, Department of Pharmaceutics Director, Brain Barriers Research Center
University of Minnesota

Manmeet S. Ahluwalia
Manmeet S. Ahluwalia, MD, MBA Chief of Medical Oncology, Chief Scientific Officer & Deputy Director
Miami Cancer Institute, Baptist Health South Florida

Day Two

Wednesday June 30, 2021

9:40 am | Learning from Oncology – Exploring Delivery of Therapeutics to CNS Tumours

10:10 am | Live Q&A with your Expert Speakers

James Gorman
Brain Targeting Program
Wyss Institute for Biologically Inspired Engineering

Day One

Tuesday June 29 2021

1:00 pm | Live Q&A with Your Expert Speakers

Day Two

Wednesday June 30, 2021

4:30 pm | Live Q&A with Your Expert Speakers

Axel Meyer
Principal Research Scientist I, BBB & Advanced ADME
AbbVie

Day Two

Wednesday June 30, 2021

12:00 pm | A Novel Solid Lipid Nanoparticle Formulation for Successful Drug Delivery Across the BBB

1:30 pm | Live Q&A with Your Expert Speakers

11:00 am | Panel Discussion: Challenges and Opportunities in Nanoparticle Engineering for Brain Targeting - Focus on Intravenous Routes of Injection

Maria Deli
Maria Deli, Scientific Adviser, Group Leader
Biological Research Centre, Szeged, Hungary

Katherine Deng
Principal Scientist
AbbVie

Day Two

Wednesday June 30, 2021

4:30 pm | Live Q&A with Your Expert Speakers

3:00 pm | In Vitro BBB Models for Biologic Drug Screening

Sungwon An
Director
ABL Bio

Day One

Tuesday June 29 2021

1:00 pm | Live Q&A with Your Expert Speakers

12:00 pm | Application of Grabody B, an IGF1R-Mediated BBB Shuttle

Steve Stice
CSO
Aruna Bio, Inc

Day One

Tuesday June 29 2021

6:10 pm | Live Q&A with Your Expert Speakers

5:10 pm | Neural Extracellular Vesicle Role in Noninvasive CNS Drug Delivery

Anna Jezierski
Research Officer, Human Health Therapeutics Research Centre
National Research Council of Canada

Day Two

Wednesday June 30, 2021

4:30 pm | Live Q&A with Your Expert Speakers

3:30 pm | Application of BBB-on-chip Models in Pre-Clinical Assessment of Glioblastoma-Targeting CAR-T Based Immunotherapies

Danica Stanimirovic
Director, Translational Bioscience, Human Health Therapeutics Research Centre
National Research Council of Canada

Day One

Tuesday June 29 2021

8:40 am | Kick-off Panel Discussion: Exploring the Biggest Hurdles of Crossing the Blood-Brain Barrier (BBB) & Considerations for Overcoming Them

Will Costain
Senior Research Officer, Human Health Therapeutics Research Centre
National Research Council of Canada

Day One

Tuesday June 29 2021

1:00 pm | Live Q&A with Your Expert Speakers

11:30 am | Enabling Peripheral Enzyme Replacement Therapy to Alleviate CNS Pathology in Lysosomal Storage Disease

Jean-François Ghersi-Egea
Research Director
INSERM

Day One

Tuesday June 29 2021

4:40 pm | Targeting the “Other” Blood-Brain Barriers for Cerebral Drug Delivery

6:10 pm | Live Q&A with Your Expert Speakers

Raleigh Linville
Post-doc, Searson Group, Johns Hopkins
Institute for NanoBioTechnology

Day Two

Wednesday June 30, 2021

4:30 pm | Live Q&A with Your Expert Speakers

4:00 pm | State-of-the-Art Tissue-Engineered Models of the Human Blood-Brain Barrier

Susan Rosenbaum
Founder, Chairman, CEO
Lauren Sciences LLC

Day Two

Wednesday June 30, 2021

1:30 pm | Live Q&A with Your Expert Speakers

11:30 am | The Brain Delivery Trifecta: Triple-Targeted, Non-Invasive CNS Platform for Non-BBB Penetrants

Karin Otte
Principal Scientist
Merck

Day One

Tuesday June 29 2021

6:10 pm | Live Q&A with Your Expert Speakers

5:40 pm | CNS Drug Discovery: A Strategy to Develop Freely Penetrant CNS Drugs

Jonathan Sugam
Associate Principal Scientist, Neuroscience Discovery
Merck

Day One

Tuesday June 29 2021

8:40 am | Kick-off Panel Discussion: Exploring the Biggest Hurdles of Crossing the Blood-Brain Barrier (BBB) & Considerations for Overcoming Them

Moein Moghimi
Professor of Pharmaceutics & Nanomedicine Newcastle University
Newcastle University

Day Two

Wednesday June 30, 2021

1:30 pm | Live Q&A with Your Expert Speakers

1:00 pm | Nanoligand Carriers: A Versatile Self-Assembly Platform for the Delivery of Macromolecular Therapeutics to the Brain

11:00 am | Panel Discussion: Challenges and Opportunities in Nanoparticle Engineering for Brain Targeting - Focus on Intravenous Routes of Injection

Manuel Sanchez-Felix
Senior Fellow, Novel Delivery Technologies
Novartis Institute for Biomedical Research

Day One

Tuesday June 29 2021

8:40 am | Kick-off Panel Discussion: Exploring the Biggest Hurdles of Crossing the Blood-Brain Barrier (BBB) & Considerations for Overcoming Them

Day Two

Wednesday June 30, 2021

11:00 am | Panel Discussion: Challenges and Opportunities in Nanoparticle Engineering for Brain Targeting - Focus on Intravenous Routes of Injection

Pawel Stocki
Director of Research
Ossianix

Day One

Tuesday June 29 2021

1:00 pm | Live Q&A with Your Expert Speakers

11:00 am | Blood-Brain Barrier Delivery in Non-Human Primates by Single Domain VNAR Antibodies to TfR1

Felix Schumacher
Program Leader Targeted Therapeutics
Roche

Day One

Tuesday June 29 2021

3:30 pm | Live Q&A with Your Expert Speakers

8:40 am | Kick-off Panel Discussion: Exploring the Biggest Hurdles of Crossing the Blood-Brain Barrier (BBB) & Considerations for Overcoming Them

Peter Westenskow
Senior Principal Scientist & Section Head
Roche

Day One

Tuesday June 29 2021

6:10 pm | Live Q&A with Your Expert Speakers

4:10 pm | BBB-Improving Strategies to Prevent Retinopathies

Stina Syvänen
Associate Professor
Uppsala University

Day One

Tuesday June 29 2021

1:00 pm | Live Q&A with Your Expert Speakers

12:30 pm | Bispecific Brain-Penetrating Antibodies – New Possibilities for In Vivo Brain Imaging

Emmanuelle Canet Soulas
Professor of Physiology, University of Lyon, CarMeN lab
INSERM

Day Two

Wednesday June 30, 2021

1:30 pm | Live Q&A with Your Expert Speakers

12:30 pm | Exploring Applications of PET-MRI Nanoparticles for Multimodal Imaging of the BBB

José Obeso
Professor of Neurology
HM-CINAC Fundacion Hospitales de Madrid & CEU-San Pablo University

Day Two

Wednesday June 30, 2021

10:10 am | Live Q&A with your Expert Speakers

9:10 am | Opening the BBB in Parkinson´s Disease and Other Neurodegenerations: A Window into Disease Modification

Raphael Lis
Assistant Professor
Weill Cornell Medical College

Day Two

Wednesday June 30, 2021

4:30 pm | Live Q&A with Your Expert Speakers

2:30 pm | Human Induced Pluripotent Stem Cell-derived Brain Endothelial Cells: Current Controversies and Progress

Nathalie Agar
Associate Professor of Neurosurgery & Radiology
Harvard Medical School

Michelle Erickson
Research Assistant Professor
VA Puget Sound

Day One

Tuesday June 29 2021

3:30 pm | Live Q&A with Your Expert Speakers

3:00 pm | Exploring Mechanisms of SARS-CoV-2 Brain Entry: a Focus on the Blood-Brain Barrier

Carsten Hagemann
Head of the Tumorbiology Laboratory Department of Neurosurgery
University Hospital Wuerzburg

Day One

Tuesday June 29 2021

9:30 am | Leveraging Tumor Treating Fields (TTFields) to Overcome the BBB

Nathalie Cartier
Head of NeurogenCell Lab, Paris Brain Institute (ICM), INSERM, Paris Sorbonne University, CNS Expert
Asklepios BioPharmaceutical, Inc.

Day One

Tuesday June 29 2021

3:30 pm | Live Q&A with Your Expert Speakers

2:00 pm | Crossing the Blood-Brain Barrier to Improve CNS Gene Therapy: From Preclinical Models to Clinical Applications

Amber D. Van Laar
VP Clinical Development
Asklepios BioPharmaceutical, Inc.

Day One

Tuesday June 29 2021

3:30 pm | Live Q&A with Your Expert Speakers

2:30 pm | Overcoming the BBB with Direct CNS Delivery: Advantages and Challenges

William A. Banks
Associate Chief of Staff - Research & Development, VA Puget Sound Professor, Division of Gerontology & Geriatric Medicine, Department of Medicine
University of Washington